2004
DOI: 10.1124/mol.104.002758
|View full text |Cite
|
Sign up to set email alerts
|

Designing Transcription Factor Architectures for Drug Discovery

Abstract: Recent advances in the design, selection, and engineering of DNA binding proteins have led to the emerging field of designer transcription factors (TFs). Modular DNA-binding protein domains can be assembled to recognize a given sequence of a DNA in a regulatory region of a targeted gene. TFs can be readily prepared by linking the DNA-binding protein to a variety of effector domains that mediate transcriptional activation or repression. Furthermore, the interaction between the TF and the genomic DNA can be regu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
124
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 164 publications
(124 citation statements)
references
References 98 publications
0
124
0
Order By: Relevance
“…These results clearly demonstrate that the observed effects were not due to special properties of ZFs Zif268 and PBSII, but can be achieved using other custom ZFs, such as PE1A. This feature suggests that SEERs can be rapidly designed to detect virtually any desired DNA sequence using custom ZF DNA-binding technology (14,15).In summary, we have demonstrated the use of TEM-1 β-lactamase to improve the sequenceenabled enzyme reactivation method for the detection of double-stranded DNA. The assay can detect its target sequence rapidly and with high specificity.…”
mentioning
confidence: 61%
See 1 more Smart Citation
“…These results clearly demonstrate that the observed effects were not due to special properties of ZFs Zif268 and PBSII, but can be achieved using other custom ZFs, such as PE1A. This feature suggests that SEERs can be rapidly designed to detect virtually any desired DNA sequence using custom ZF DNA-binding technology (14,15).In summary, we have demonstrated the use of TEM-1 β-lactamase to improve the sequenceenabled enzyme reactivation method for the detection of double-stranded DNA. The assay can detect its target sequence rapidly and with high specificity.…”
mentioning
confidence: 61%
“…These custom-made ZF proteins can be linked to functional domains to generate novel chimeric proteins that produce the desired activity at specific DNA sequences. This approach has been employed in designing targeted transcription factors (14,16), targeted endonucleases (17), and targeted integrases (18).…”
mentioning
confidence: 99%
“…Each ZF domain specifically recognizes 3 base pairs (bps) of DNA (Pavletich and Pabo, 1991). Thus, a designed 6ZF ATF will recognize 18-bp, providing high degree of specificity (Blancafort et al, 2004;Beltran et al, 2006). Indeed, previous reports have described that highly specific 6ZF ATFs are able to target unique sites in the human genome (Tan et al, 2003).…”
Section: Resultsmentioning
confidence: 99%
“…Typically, three zinc fingers are combined to bind to a specific 9-bp DNA sequence with the nanomolar affinity required to be biologically useful, but additional fingers can be incorporated to confer increased specificity (8-11). Zinc-finger fusions to various functional domains have been used to create artificial transcription factors and DNA-modifying proteins (12,13).When attached to the FokI nuclease domain, zinc fingers can direct cleavage to specific DNA sequences. The nuclease domain must dimerize to cleave DNA (14), and because the dimer interface is weak (15), two nuclease domains are typically brought into close proximity by pairs of zinc-finger sets binding to neighboring sites.…”
mentioning
confidence: 99%
“…Typically, three zinc fingers are combined to bind to a specific 9-bp DNA sequence with the nanomolar affinity required to be biologically useful, but additional fingers can be incorporated to confer increased specificity (8)(9)(10)(11). Zinc-finger fusions to various functional domains have been used to create artificial transcription factors and DNA-modifying proteins (12,13).…”
mentioning
confidence: 99%